Research Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Comparing the effectiveness of Pilates and circuit-based exercise in reducing joint pain during hormone therapy for women with breast cancer.

Comparing the effectiveness of Pilates and circuit-based exercise in reducing joint pain during hormone therapy for women with breast cancer.

Posted by on May 6, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated the effectiveness of Pilates compared with circuit-based exercise in reducing joint pain during hormone therapy for women with breast cancer. The data showed that Pilates was more effective than circuit-based exercise in reducing joint pain for these patients. Some background Many of the patients with...

Read More

Which treatment is best for patients with stable ischemic heart disease?

Which treatment is best for patients with stable ischemic heart disease?

Posted by on May 6, 2021 in Coronary artery disease | 0 comments

In a nutshell This study compared the treatment of stable ischemic heart disease (SIHD) with percutaneous coronary angioplasty (PCI) or with medication alone. It found that the risk of mortality was the same in both groups. Some background Coronary artery disease (CAD) is when the blood vessels in the heart become blocked and the heart muscle...

Read More

Can ertugliflozin improve diabetes and blood pressure in patients who have heart disease?

Can ertugliflozin improve diabetes and blood pressure in patients who have heart disease?

Posted by on May 6, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the ertugliflozin (Steglatro) for patients with type 2 diabetes (T2D) and heart disease. It found that ertugliflozin improved both blood glucose control, body weight, and blood pressure. Some background T2D is a condition in which the levels of glucose (sugar) in the blood are too high. T2D is related to...

Read More

Is daratumumab plus RVd a good treatment for patients with newly diagnosed multiple myeloma in the long-term?

Is daratumumab plus RVd a good treatment for patients with newly diagnosed multiple myeloma in the long-term?

Posted by on May 6, 2021 in Multiple Myeloma | 0 comments

In a nutshell The aim of this study was to evaluate the long-term safety and effectiveness of adding daratumumab (Darzalex) to RVd (lenalidomide/bortezomib/dexamethasone) therapy, followed by D-R (daratumumab/lenalidomide) maintenance for patients with newly diagnosed multiple myeloma (MM). The study found that this treatment was well tolerated...

Read More

Comparing the outcomes of Retzius-sparing versus standard robotic prostate surgery for the treatment of localized prostate cancer.

Comparing the outcomes of Retzius-sparing versus standard robotic prostate surgery for the treatment of localized prostate cancer.

Posted by on May 6, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the outcomes of Retzius-sparing (RS) robotic-assisted laparoscopic prostatectomy (RALP) with standard RALP (sRALP) for the treatment of patients with localized prostate cancer (PCa). The study found that the RS-RALP approach may be associated with better urinary outcomes compared to sRALP. Some background...

Read More

Can nivolumab plus ipilimumab combined with chemotherapy be used as a first-line treatment for patients with non-small cell lung cancer?

Can nivolumab plus ipilimumab combined with chemotherapy be used as a first-line treatment for patients with non-small cell lung cancer?

Posted by on May 6, 2021 in Lung cancer | 0 comments

In a nutshell This trial looked at nivolumab (Opdivo) plus ipilimumab (Yervoy) combined with 2 cycles of chemotherapy as treatment for patients with non-small cell lung cancer (NSCLC). The authors found that this combination provided an improved overall survival versus chemotherapy-only regimens. Some background NSCLC is responsible for 85% of...

Read More

Evaluating the combination of sipuleucel-T with radium-223 in men with metastatic castration-resistant prostate cancer spread to the bone.

Evaluating the combination of sipuleucel-T with radium-223 in men with metastatic castration-resistant prostate cancer spread to the bone.

Posted by on May 3, 2021 in Prostate cancer | 0 comments

In a nutshell The study investigated the effectiveness of combining sipuleucel-T (Provenge) with radium-223 (Xofigo) therapy in men with castration-resistant prostate cancer (CRPC) that has spread to the bones. The key finding was that the combination therapy improved the survival rates of these patients.  Some background Prostate cancer often...

Read More

Can physical exercise improve the quality of life of patients with prostate cancer?

Can physical exercise improve the quality of life of patients with prostate cancer?

Posted by on Apr 30, 2021 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the effectiveness of physical exercise in patients with prostate cancer. The study concluded that physical exercise is associated with reduction of tiredness, and improving functional capacity and quality of life in these patients. Some background Prostate cancer (PCa) is the second most common form of...

Read More

Evaluating pirtobrutinib for the treatment on B cell leukemia/lymphoma

Evaluating pirtobrutinib for the treatment on B cell leukemia/lymphoma

Posted by on Apr 30, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study tested the safety and effectiveness of pirtobrutinib (LOXO-305) in the treatment of patients with B cell leukemia/lymphoma. The authors found that pirtobrutinib was safe and had promising effectiveness in these patients. Some background B cells are a type of cell of the immune system. Some lymphomas and leukemias such as...

Read More